No eligible episode link is available for this item yet.
No eligible free trial linkavailable.
Podcast Episode
#Ad
Amazon Music Free Trial
#Ad
Understanding Cardiovascular Disease Risk, Cholesterol, and ApoB features Peter Attia (MD) with Allan Sniderman (MD) and Thomas Dayspring (MD, FACP, FNLA, NCMP) exploring the science behind atherosclerosis prevention. They discuss why early intervention matters, the role of lipoproteins, and the shortcomings of standard blood panels. The conversation highlights apoB as a superior metric for assessing risk, explains its causal role in ASCVD, and outlines therapeutic targets. Listeners gain insight into how lowering apoB early could transform cardiovascular disease prevention.
Description
Understanding Cardiovascular Disease Risk, Cholesterol, and ApoB
Guest
Allan Sniderman, Tom Dayspring
Category
Cardiovascular Health, Metabolic Health
Tags
About The Host
Peter Attia (MD) is a physician specializing in preventive health, longevity, and high-performance living. He hosts The Peter Attia Drive, where in-depth conversations with scientists and health experts explore aging, chronic disease prevention, and performance optimization. His book "Outlive: The Science and Art of Longevity" combines research, clinical insight, and actionable strategies to help readers extend their healthspan, strengthen resilience, and make informed choices for a longer, more vibrant life.
Peter Attia (MD) is a physician specializing in preventive health, longevity, and high-performance living. He hosts The Peter Attia Drive, where in-depth conversations with scientists and health experts explore aging, chronic disease prevention, and performance optimization. His book "Outlive: The Science and Art of Longevity" combines research, clinical insight, and actionable strategies to help readers extend their healthspan, strengthen resilience, and make informed choices for a longer, more vibrant life.
About The Guest
Allan Sniderman (MD) and Thomas Dayspring (MD, FACP, FNLA, NCMP) are leading authorities on lipids and cardiovascular disease prevention. Sniderman, a professor of cardiology at McGill University, has been instrumental in promoting apoB as a critical measure for assessing heart disease risk. Dayspring is an internationally known lipid specialist and educator who has trained thousands of clinicians in advanced lipid management. Their combined expertise continues to influence how cardiovascular risk is understood, measured, and addressed in modern preventive care.
Allan Sniderman (MD) and Thomas Dayspring (MD, FACP, FNLA, NCMP) are leading authorities on lipids and cardiovascular disease prevention. Sniderman, a professor of cardiology at McGill University, has been instrumental in promoting apoB as a critical measure for assessing heart disease risk. Dayspring is an internationally known lipid specialist and educator who has trained thousands of clinicians in advanced lipid management. Their combined expertise continues to influence how cardiovascular risk is understood, measured, and addressed in modern preventive care.
Support the Guest
This episode does not include any guest appearances, or information about the guests' website, Instagram, Facebook, or Twitter profiles is currently unknown to us. We’ll update this page as soon as more details become available.
Disclaimer
This page links to third-party audio content for general educational purposes only and is not medical advice. Views, claims, and recommendations belong to the host and guests; we do not guarantee accuracy or outcomes and do not endorse every statement. Consult a qualified healthcare professional before starting detoxes, restrictive diets, supplements, or treatment changes, especially if pregnant, under 18, on medication, or managing a medical condition.